Verastem Q3 EPS $(0.71) Beats $(0.84) Estimate
Portfolio Pulse from Benzinga Newsdesk
Verastem (NASDAQ:VSTM) reported Q3 losses of $(0.71) per share, beating the analyst consensus estimate of $(0.84) by 15.48 percent. This represents a 26.04 percent increase over losses of $(0.96) per share from the same period last year.
November 08, 2023 | 10:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Verastem's Q3 earnings beat analyst estimates by 15.48%, showing a 26.04% improvement over last year's losses.
Verastem's Q3 earnings beat analyst estimates, which is generally seen as a positive sign by investors. The fact that the losses are less than the same period last year also indicates an improvement in the company's financial performance, which could lead to a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100